Fig. 9From: Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231)UV-Illumination of fragmented DNA bands of ZnO NPs and modified ZnO NPs treated cells in 1.2 % Agarose gel along with control untreated cells (leftmost) and 100 bps ladder (rightmost) segregated on 5 V/cm for 2 hBack to article page